For every drug or treatment out there, someone has had it tested on them to get it approved. 

So what actually happens in clinical trials?

Some clinical drug trials can go on for months with participants receiving hundreds, or even thousands of dollars. But they don’t all end well.  

Dr Sophie Calabretto talks to Cosmos Magazine journalist Jacinta Bowler about why clinical trials are still the best process we have, how they can go wrong and why so many drugs fail to make it to market.

For every drug or treatment out there, someone has had it tested on them to get it approved. 
So what actually happens in clinical trials?
Some clinical drug trials can go on for months with participants receiving hundreds, or even thousands of dollars. But they don’t all end well.  
Dr Sophie Calabretto talks to Cosmos Magazine journalist Jacinta Bowler about why clinical trials are still the best process we have, how they can go wrong and why so many drugs fail to make it to market.

This is The Science Briefing, a podcast about the science of everything and your new go-to podcast for your snapshot of science news. Hosted by Dr Sophie Calabretto and featuring journalists from Cosmos Magazine, The Science Briefing brings you the latest research in technology, health, climate, physics, artificial intelligence, space and more. Hear what’s making news in science in Australia and across the globe every Tuesday and Thursday. Search The Science Briefing, or download the LiSTNR app to listen for free. 

This is The Science Briefing, a podcast about the science of everything and your new go-to podcast for your snapshot of science news. Hosted by Dr Sophie Calabretto and featuring journalists from Cosmos Magazine, The Science Briefing brings you the latest research in technology, health, climate, physics, artificial intelligence, space and more. Hear what’s making news in science in Australia and across the globe every Tuesday and Thursday. Search The Science Briefing, or download the LiSTNR app to listen for free.

Advertisement